| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |